Metraipolis › archive › dc_6e4e720b51a9

Progress in molecular markers associated with radiotherapy efficacy in glioma — Europe PMC PMID:42125691

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42125691
DOI
10.3389/fonc.2026.1734404
License (as archived)
solo-consultazione
Archived
2026-11-03T04:41:52.807Z
SHA-256 of the archived text
ff308d12437fa86d7a2ee153d5185c76e620bb49ebadec00f3275b3b1bc799cb
Stable URL of this page
https://metraipolis.com/documento/dc_6e4e720b51a9

How to cite

Progress in molecular markers associated with radiotherapy efficacy in glioma — Europe PMC PMID:42125691 — Europe PMC (en), https://europepmc.org/article/MED/42125691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e4e720b51a9 (Metraipolis archive dc_6e4e720b51a9, sha256 ff308d12437fa86d7a2ee153d5185c76e620bb49ebadec00f3275b3b1bc799cb)
BibTeX
@misc{dc6e4e720b51a9,
  title = {Progress in molecular markers associated with radiotherapy efficacy in glioma — Europe PMC PMID:42125691},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42125691},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e4e720b51a9; sha256 ff308d12437fa86d7a2ee153d5185c76e620bb49ebadec00f3275b3b1bc799cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42125691. Agents can read the archived copy with the MCP tool read_document.